12 Health Care Stocks Moving In Friday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Friday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included Bolt Biotherapeutics (up 58.8%), Lucid Diagnostics (up 34.26%), and Estrella Immunopharma (up 27.26%). Conversely, major losers featured Aardvark Therapeutics (down 56.5%), Lunai Bioworks (down 50.43%), and Lakewood-Amedex (down 39.9%). The report highlights these price movements alongside respective market capitalizations for the listed companies.
Gainers
- Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday's regular session. The market value of their outstanding shares is at $7.9 million.
- Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 34.26% to $0.44. The market value of their outstanding shares is at $63.6 million.
- Estrella Immunopharma (NASDAQ:ESLA) stock moved upwards by 27.26% to $0.92. The company's market cap stands at $23.9 million.
- Streamex (NASDAQ:STEX) stock increased by 27.14% to $0.45. The market value of their outstanding shares is at $42.9 million.
- Nautilus Biotechnology (NASDAQ:NAUT) shares rose 20.57% to $3.13. The company's market cap stands at $344.8 million.
- NeOnc Technologies Hldgs (NASDAQ:NTHI) shares rose 17.96% to $3.48. The company's market cap stands at $83.5 million.
Losers
- Aardvark Therapeutics (NASDAQ:AARD) stock fell 56.5% to $1.72 during Friday's regular session. The market value of their outstanding shares is at $96.5 million.
- Lunai Bioworks (NASDAQ:LNAI) stock fell 50.43% to $0.23. The market value of their outstanding shares is at $2.3 million.
- Lakewood-Amedex (NASDAQ:LABT) stock fell 39.9% to $0.29. The market value of their outstanding shares is at $1.1 million.
- Pomdoctor (NASDAQ:POM) shares decreased by 34.98% to $1.32. The company's market cap stands at $8.3 million.
- Macrogenics (NASDAQ:MGNX) stock decreased by 33.65% to $2.41. The market value of their outstanding shares is at $228.6 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock decreased by 25.5% to $2.27. The market value of their outstanding shares is at $7.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock989characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.